← Back to Search

Machine Learning Model

Data-Driven Screening for Substance Use Disorders

N/A
Recruiting
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18 years old to 89 years old
Inpatient status during hospitalization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months enrollment with 6 months follow-up for rehospitalization
Awards & highlights

Study Summary

This trial aims to create a machine learning model to scan hospital patient records & detect substance misuse, providing a standardized approach for better screening & treatment.

Who is the study for?
This trial is for hospitalized patients aged 18 to 89 who are staying longer than a day. It's not for those transferred to/from another acute hospital, unable to participate in usual care interventions, discharged against advice, or critically ill within the first day.Check my eligibility
What is being tested?
The study is testing a machine learning model that processes clinical notes from electronic health records (EHR) to identify substance misuse. The goal is an automated daily screen tool for all hospitalized patients.See study design
What are the potential side effects?
Since this trial involves data processing and not medical treatments or drugs, there are no direct physical side effects associated with participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 89 years old.
Select...
I am currently admitted to the hospital.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months enrollment with 6 months follow-up for rehospitalization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months enrollment with 6 months follow-up for rehospitalization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients that had a universal screen positive and received SBIRT (screening, brief intervention, or referral to treatment)
Secondary outcome measures
All-cause re-hospitalizations following 6-months from the Index hospital encounter

Trial Design

1Treatment groups
Experimental Treatment
Group I: NLP (natural language processing) pre-screenExperimental Treatment1 Intervention
Automated processing of clinical notes collected during routine care in first 24 hours of hospital admission to identify individuals at-risk for substance misuse to receive standard-of-care full screening and assessment, brief intervention, or referral to treatment (SBIRT) intervention.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterOTHER
422 Previous Clinical Trials
128,701 Total Patients Enrolled
1 Trials studying Substance Abuse
801 Patients Enrolled for Substance Abuse
University of Wisconsin, MadisonLead Sponsor
1,187 Previous Clinical Trials
3,134,697 Total Patients Enrolled
1 Trials studying Substance Abuse
53,132 Patients Enrolled for Substance Abuse

Media Library

Data-driven Identification for Substance Misuse (Machine Learning Model) Clinical Trial Eligibility Overview. Trial Name: NCT03833804 — N/A
Substance Abuse Research Study Groups: NLP (natural language processing) pre-screen
Substance Abuse Clinical Trial 2023: Data-driven Identification for Substance Misuse Highlights & Side Effects. Trial Name: NCT03833804 — N/A
Data-driven Identification for Substance Misuse (Machine Learning Model) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03833804 — N/A
Substance Abuse Patient Testimony for trial: Trial Name: NCT03833804 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it within my capabilities to partake in this medical experiment?

"This trial is looking for 34800 individuals between 18 and 89 years old that suffer from a substance use disorder. To be considered, applicants must meet these criteria."

Answered by AI

Does the eligibility for this investigation incorporate those under thirty years old?

"This medical study only accepts patients between the ages of 18-89. By contrast, there are 72 trials for minors and 244 for elderly adults."

Answered by AI

Are researchers still recruiting participants for this investigation?

"On clinicaltrials.gov, this medical research is actively recruiting participants - it was first published on February 1st 2023 and the listing was recently updated on February 27th 2023."

Answered by AI

How many individuals are enrolled in this research project?

"Affirmative. The clinicaltrials.gov website has the latest information, showing that this ongoing trial commenced on February 1st 2023 and was updated most recently on February 27th of the same year. Over 34 thousand individuals are needed for participation at a single site."

Answered by AI

Who else is applying?

What state do they live in?
Wisconsin
What site did they apply to?
Rush University Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

i am curious as to my abilities on this subject.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Data-driven Identification for Substance Misuse
2023. "Data-driven Identification for Substance Misuse". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03833804.
All > Substance Abuse
~13617 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top